Introduction
Heterocyclic sulfonamides possessing carbonic anhydras (CA, EC 4.2.1.1) inhibitory properties are clinically used pharmacological agents in the treatment of a variety of diseases. 2 Thus, acetazolamid 1 and some other thiadiazole-sulfonamides derived from 2, methazolamid 3, thoxzolamide 4 R2 N'L.,.S SO2NH2 6" R = Alkyl; hydroxyalkyl 7" RI= H, Me, Ph; R2 = alkyl 8:R1 = R2 = H
As it was observed that sulfonamides possessing a bicyclic ring system such as 4 or 5 are generally stronger inhibitors for several of the eight CA isozymes presently known in vertebrates, 4 as compared to derivatives containing only one such homo-or heterocyclic ring system, 2a,5 much synthetic work has been devoted to the preparation and evaluation of such compounds, in order to obtain stronger and more selective inhibitors, for diverse medical applications. [6] [7] [8] Compounds such as 6 and 7, 8 not only showed excellent inhibitory properties against the major red ceil isozyme, CA II, 2,3 but also possessed interesting pharmacological qualities, making them candidates for the development of topical antiglaucoma agents in the cas of 6, ,8 and selctiv cerebrovasodilators, in the case of 7. 6 As no selective such pharmacological agents are known up to now, the development of a selective cerebrovasodilator would constitute a good approach for th treatment of Vol. 4, No. 1, 1997 Inhibition of Carbonic Anhydrase Isozymes L II and IV with Metal complexes oflmidazo[2,1-b]-l 3 4-Thiadiazole-2-Sulf onamide cerebrovascular disease, a condition becoming more stringent in the last period, as the number of elderly people is increasing. 6 Recently, it was also reported 9,1 that metal complexes of heterocyclic sulfonamides such as 1-5 behave as even stronger CA inhibitors as compared to the ligands from which they derive. Thus, a large number of such derivatives were prepared and assayed as inhibitors of three CA isozymes up to now, i.e., CA I, II and IV, in the search for isozyme-specific inhibitors. Continuing our research for specific inhibitors, in this paper we report the preparation of metal complexes of sulfonamide 8 possessing very good CA inhibitory properties. The Zn(II), Cd(II), Hg(II), Co(II), Ni(II), Cu(II), V(IV), F(III) 15 Non-enzymatic hydrolysis rates were always subtracted from the observed rates. Duplicate experiments were done for each inhibitor, and the values reported throughout the paper are the averages of such results. ICs0 represents the molarity of inhibitor producing a 50% decrease of enzyme catalyzed hydrolysis of 4-nitrophenyl acetate.
1.80 g (10 mmol) of 5-amino-l,3,4-thiadiazole-2-sulfonamide 2 and 1.4 mL (10 mmol) of triethylamine were suspended in 50 mL of anhydrous acetonitrile, then 1.27 mL (11 mmol) of diethyl chloroacetal were added and the mixture was magnetically stirred at room temperature for 5 hours and then heated at refluxation for 24 hours. The title compound precipitated by cooling, was filtered and recrystallized from ethanol (69 % yield ). Presumably, a Schiff base intermediate is formed during the first step, as reported for related sulfonamide derivatives, 16 which subsequently cyclizes intramolecularly, in the presence of triethylamine, with formation of the imidazo-thiadiazole ring system. 6a The title compound was previously reported as hydrobromide salt (m.p. 207-210C) 6a being obtained with a 26 % yield, by a synthetic procedure similar to the one described above, except for the lack of triethylarnine in the reaction medium. 6a As seen from our data, the use of the base leads to a highly improved synthesis yield. The title compound o was obtained as a white powder, m.p. 255-258 C; IR (KBr),.cm" 633, 709, 752, 915, 1030, 1175, 1358, 1540, 1610, 3160 assumption. Thus, the characteristic band of the conjugated thiadiazolo-sulfonamide system, appearing at 262 nm in the spectrum of 8, undergoes bathochromic shifts (with 8-17 nm) and hyperchromic effects in the sodium salt of 8 (data not shown) as well as the complexes 9-17, similarly to other metal complexes of sulfonamides of type [1] [2] [3] [4] [5] previously reported by us. 9, 10 Conductimetry proved the non-electrolyte nature of 8 and of all complexes 9-17, whereas TG analysis detected the presence of two coordination water molecules in the Co(II) and Ni(II) derivatives (Table  II) . No decomposition steps under 250C were evidenced for the other metal complexes, whereas at higher temperatures intricate decomposition patterns were observed, with oxidation of the organic moieties of the complexes (data not shown). 22 A. Scozzafava and C. Supuran Metal-Based Drugs Diffuse reflectance electronic spectra and magnetic susceptibility data at room temperature of the complexes containing paramagnetic metal ions (Table III) indicated the geometry of the central metal ions, which are square pyramidal for V(IV), 17 octahedral for Fe(III), 18 Co(II), 19 and Ni(II), 20 and presumably distorted terahedral for Cu(II). 21 All these derivatives present electronic spectra and magnetic moments characteristic of these metal ions in the above mentioned surroundings. 17"21 In the EPR spectrum of the Cu(II) complex 16, a large snal was detected with g+/-1.95 and g//= 2.23, characteristic of Cu(II) in distorted tetrahedral geometry, z
The diamagnetic complexes 9-11 and 17 had 1H-NMR spectra similar to that of 8, except for the fact that. the SO NH2 resonance, a broad singlet (2H) at 8.48 ppm in the spectrum of 8, appeared as very broad sgnals at ].50-8.55 ppm in the spectra of the complexes (data not shown), which were integrated for H, obviously due to the fact that the sulfonamido moiety was deprotonated.
The above data prompted us to propose tetrahedral geometries for Zn(II), Cd(II) and Hg(II) in the newly prepared compounds, whereas the silver derivative probably contains Ag(I) in a linear geometry.
Thus, the donor system of the bidentate ligand used for the preparation of metal complexes reported here is quite similar to those of acetazolamide 1, methazolamide 3 and ethoxzolamide 4, 9,1 consisting of the deprotonated sulfonamide moiety and the endocyclic N-3 atom of the thiadiazolic ring. An exception seems to be the Ag(I) derivative 17, possessing IR and electronic spectra quite different of the other prepared complexes, which prompted us to hypothesize that the ligand acts monodentately in this case, by means of the deprotonated sulfonamido moiety, whereas the second coordination position of Ag(I) is occupied by the imidazolic nitrogen o,f another ligand molecule, leading thus to a polynuclear derivative as shown schematically below. In fact, some Ag(I) complexes of aromatic (bactericidal) sulfonamides were shown to possess such a structure. 22 The proposed structures for the new derivatives are Shown below. 
